Archived Newsletters

  1. 05.19.26 -- Early CDMO Engagement For Cell Therapies? CellProthera's CEO Thinks Not 5/19/2026
    05/19/26 Outsourced Pharma Newsletter
  2. 05.18.26 -- Selecting a Sustainable CDMO Partner for your Small Molecule Program 5/18/2026

    05/18/26 Outsourced Pharma Newsletter

  3. 05.18.26 -- STREAM Smarter Strategies For Biopharma Development And Manufacturing 5/18/2026
    05/18/26 Outsourced Pharma Newsletter
  4. 05.18.26 -- Kodak's CEO Leans Into Biopharma Manufacturing – "I'm An Operator" 5/18/2026

    05/18/26 Outsourced Pharma Newsletter

  5. 05.15.26 -- Key Manufacturing & Analytics Insights For Cell & Gene Therapies 5/15/2026
    05/15/26 Outsourced Pharma Newsletter
  6. 05.15.26 -- With CDMOs Like This, Who Needs Biotechs? 5/15/2026
    05/15/26 Outsourced Pharma Newsletter
  7. 05.14.26 -- Analytics, Infrastructure, And Partnerships Supporting Confident Scale‑Up 5/14/2026

    05/14/26 Outsourced Pharma Newsletter

  8. 05.14.26 -- Vaccine Platform Vs. CDMO Model: Outsourcing Lessons For All Biopharma 5/14/2026
    05/14/26 Outsourced Pharma Newsletter
  9. 05.13.26 -- Drug Product Development: Inside CDMO Capabilities That Matter 5/13/2026

    05/13/26 Outsourced Pharma Newsletter

  10. 05.13.26 -- Kodak Flips The Script To Pharmaceutical Manufacturing In Rochester 5/13/2026
    05/13/26 Outsourced Pharma Newsletter